REVERSING THE BREAK POINT: MANAGEMENT OF OCULAR SURFACE AFTER ANTERIOR SEGMENT SURGERIES

Article Sidebar

PDF
Published: Aug 29, 2024
Keywords:
Ocular Surface, Conjunctival Erosion, Anterior Segment Surgery, Treatment Algorithm, Artificial Tears

Main Article Content

Nirmit Shah
Melbourne Medical School, University of Melbourne, Ground Floor, Medical Building, Corner of Grattan Street & Royal Parade, University of Melbourne, VIC 3052, Australia; Ocular Health Centre, 31 Kingsbury Dr Unit # 501, Kitchener, ON N2A 0K5, Canada
Edward Tran
Schulich School of Medicine, University of Western Ontario, 1151 Richmond Street, London, ON N6A 3K7, Canada; Ocular Health Centre, 31 Kingsbury Dr Unit # 501, Kitchener, ON N2A 0K5, Canada
https://orcid.org/0000-0002-6215-1053
Angela Kyveris
Ocular Health Centre, 31 Kingsbury Dr Unit # 501, Kitchener, ON N2A 0K5, Canada
Toby Chan
Ocular Health Centre, 31 Kingsbury Dr Unit # 501, Kitchener, ON N2A 0K5, Canada; Michael G. DeGroote School of Medicine, McMaster University, 90 Main St W, Hamilton, ON L8P 1H6, Canada

Abstract

Background and Objective
Anterior segment surgeries such as trabeculectomies are staple procedures when managing a patient with long-standing glaucoma. However, they also come alongside an increased risk of conjunctival erosion, a complication with its detriments. Erosion can be repaired surgically and topically, yet no standard treatment algorithm guides clinicians on how to deal with this issue.


Methods
We present 3 cases in which a treatment algorithm utilizing strategic artificial tear selection successfully managed the ocular surface in patients with postoperative conjunctival erosion.


Results
Our evidence suggests the importance of effectively choosing adequate artificial tears to address the underlying issue causing conjunctival erosion. Additionally, this evidence can direct clinical judgment when managing a patient’s ocular surface issues. Future research is needed to compare these outcomes against alternative measures for dealing with conjunctival erosions.

Downloads

Download data is not yet available.

Article Details

Issue
Vol. 6 No. 1 (2024): JDED
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright of articles published in all DPG titles is retained by the author(s). The author(s) grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. The author grants any party the rights to use the article freely for non-commercial purposes provided that the original work is properly cited.

References

1. Stewart WC, Kristoffersen CJ, Demos CM, Fsadni MG, and Stewart JA. Incidence of conjunctival exposure following drainage device implantation in patients with glaucoma. Eur J Ophthalmol 2019;20(1):124–130. https://doi.org/10.1177/112067211002000117

2. Huang MC, Netland PA, Coleman AL, et al. Intermediate-term clinical experience with the Ahmed Glaucoma Valve implant. Ame J Ophthalmol 1999;127(1):27–33. https://doi.org/10.1016/s0002-9394(98)00394-8

3. Byun YS, Lee NY, and Park CK. Risk factors of implant exposure outside the conjunctiva after Ahmed glaucoma valve implantation. Japan J Ophthalmol 2009;53(2):114–119. https://doi.org/10.1007/s10384-008-0630-y

4. Rachmiel R, Trope GE, Buys YM, et al. Ahmed glaucoma valve implantation in uveitic glaucoma versus open-angle glaucoma patients. Can J Ophthalmol. 2008;43(4):462–467. https://doi.org/10.3129/i08-082

5. Mills RP, Reynolds A, Emond MJ, et al.. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology 1996;103(2):299–305. https://doi.org/10.1016/s0161-6420(96)30700-8

6. Heuer DK, Budenz D, and Coleman A. Aqueous shunt tube erosion. J Glaucoma 2001;10(6):493–496. https://doi.org/10.1097/00061198-200112000-00010

7. Whitson JT, Varner DL, and Netland PA. Glaucoma Drugs and The Ocular Surface. Review of Ophthalmology 2006. Available at : https://www.reviewofophthalmology.com/article/glaucoma-drugs-and-the-ocular-surface.

8. Leung E. W., Medeiros, F. A., & Weinreb, R. N. (2008). Prevalence of ocular surface disease in glaucoma patients. Journal of glaucoma, 17(5), 350–355. https://doi.org/10.1097/IJG.0b013e31815c5f4f

9. CandorVision. Product Homepage: Available at: https://candorvision.com/ocunox/

10. Cui X, Xiang J, Zhu W, Wei, et al. Vitamin A Palmitate and Carbomer Gel Protects the Conjunctiva of Patients With Long-term Prostaglandin Analogs Application.J Glaucoma 2016;25(6):487–492. https://doi.org/10.1097/IJG.0000000000000316

11. García-Posadas L, Contreras-Ruiz L, Soriano-Romaní L, et al. Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines. Eye Contact Lens 2016:42(2):83–90. https://doi.org/10.1097/ICL.0000000000000158

12. https://www.labticianthea.com/treatment/thealoz-duo/

13. Ozek D and Kemer OE. Effect of the bioprotectant agent trehalose on corneal epithelial healing after corneal cross-linking for keratoconus. Arquivos Brasileiros de Oftalmologia 2018;81(6):505–509. https://doi.org/10.5935/0004-2749.20180100

14. Lerner LE, Schwartz DM, Hwan DG, et al. Hyaluronan and CD44 in the human cornea and limbal conjunctiva. Experimental Eye Res 1998;67(4):481–484. https://doi.org/10.1006/exer.1998.0567

15. Chen W, Zhang X, Liu M, et al. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis. Exper Eye Res 2009;89(3):311–318. https://doi.org/10.1016/j.exer.2009.03.015

16. Matsuo T. Trehalose protects corneal epithelial cells from death by drying. British J Ophthalmol 2001;85(5):610–612. https://doi.org/10.1136/bjo.85.5.610

17. https://www.aequuseyecare.ca/pages/intensive-gel-info

18. Carracedo G, Pastrana C, Serramito M, and Rodriguez-Pomar C. Evaluation of tear meniscus by optical coherence tomography after different sodium hyaluronate eyedrops instillation. Acta Ophthalmologica 2019;97(2):e162–e169. https://doi.org/10.1111/aos.13887